CME Presentations

Pediatric Epilepsies - Part 3


Presentations


Speakers

  • Orrin Devinsky, MD

    Orrin Devinsky, MD

    Orrin Devinsky, MD

    Professor, Department of Neurology

    Orrin Devinsky, MD, is professor of neurology, neuroscience, neurosurgery, and psychiatry at the NYU School of Medicine and directs NYU Epilepsy Center and Saint Barnabas Institute of Neurology in New York. His epilepsy research includes cannabinoid therapies, genetic epilepsies and precision therapies, sudden death in epilepsy (SUDEP), quality-of-life, and surgical therapy. Dr Devinsky is the principal investigator for the North American SUDEP Registry and for the SUDC Registry and Research Collaborative. He is on the Scientific Advisory Boards for various foundations, including the Epilepsy Foundation, and chairs the Loulou Foundation CDKL5 Program of Excellence. Dr Devinsky founded Finding A Cure for Epilepsy and Seizures (FACES) and co-founded the Epilepsy Therapy Project.
  • Joseph Sullivan, MD

    Joseph Sullivan, MD

    Joseph Sullivan, MD

    Director UCSF Pediatric Epilepsy Center

    Joseph E. Sullivan, MD, is professor of neurology and pediatrics at the University of California, San Francisco (UCSF) and director of the UCSF Pediatric Epilepsy Center of Excellence at Benioff Children’s Hospital. He has served as a principal investigator in a number of clinical trials of novel drugs in the rare pediatric epilepsies. Dr Sullivan is a member of the Dravet Syndrome Foundation Medical Advisory Board and chair of the PCDH19 Alliance Scientific Advisory board. He continues to expand the UCSF Pediatric Epilepsy Center of Excellence to provide family-centric care by hiring additional specialists who can attend to the unmet psychosocial needs of patients living with epilepsy and their families. Dr Sullivan received his medical degree from Albany Medical College in New York.

CME Information

Assessing the Impact of AEDs: What Constitutes Clinical Meaningful Effect for Dravet Syndrome


Global LogoPQH Logo

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:
  • Examine seizure and non-seizure measures to evaluate treatment success with antiepileptic drugs
  • Identify strategies to critically appraise clinically meaningful measures in collaboration with families affected by Dravet syndrome
This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC.

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Zogenix, Inc.

TERM OF OFFERING

This activity was released on August 25, 2020 and is valid for 11 months. Requests for credit must be made no later than July 31, 2021.

TARGET AUDIENCE

The educational design of this activity addresses the needs of neurologists, pediatric neurologists, pediatricians and other health care professionals (including physicians, physicians-in-training, nurses, physician assistants, nurse practitioners, pharmacists, etc.) involved and/or interested in the management of patients with severe forms of pediatric intractable epilepsy.

STATEMENT OF NEED/PROGRAM OVERVIEW

For years, a 50% or greater reduction in seizure frequency has been the benchmark to assess the efficacy of anti-epileptic drugs (AEDs) in the treatment of Dravet syndrome. However, there is some concern that the use of this endpoint alone does not accurately measure outcomes that are clinically meaningful to patients. Many care visits are spent discussing non-seizure consequences of epilepsy syndromes, such as cognitive, psychological, and social issues that negatively affect patients and their families. Join Dr. Joseph Sullivan and Dr. Orrin Devinsky as they discuss the need for a validated, reliable, and usable instrument to measure non-seizure outcomes in patients. These experts will review the Clinical Global Impression of Improvement (CGI-I) as a potential efficacy measure, explore the use of disease-specific rating scales, and encourage the consideration of comorbidities that can impact treatment decisions and patent QoL as much as or more than seizure control.

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

ACPE Logo

PHARMACIST ACCREDITATION STATEMENT

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

CREDIT DESIGNATION

Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-20-089-H01-P)
This is a knowledge-based activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 1 hour to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test. For pharmacist/ACPE learners, please check the CPE monitor for your CE credit within 60 days of the activity.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Joseph Sullivan, MD Director, UCSF Pediatric Epilepsy Center Co-director, PISCES Longitudinal Integrated Clerkship Professor of Neurology & Pediatrics, UCSF Benioff Children's Hospital Consultant/Independent Contractor: Epygenix, Encoded Grant/Research Support: Zogenix, Stoke, Marinus, Biopharm Advisory Board: Invitae Stock Shareholder: Epygenix
Orrin Devinsky, MD Professor, Department of Neurology NYU Grossman School of Medicine Consultant/Independent Contractor: Tevard Biosciences, Script Biosciences, Regel Biosciences
Advisory Board: Tevard Biosciences, Script Biosciences, Regel Biosciences
Stock Shareholder: Tevard Biosciences, Script Biosciences, Regel Biosciences


The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager Reported Financial Relationship
Ashley Marostica, RN, MSN Nothing to disclose
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Carole Drexel Nothing to disclose
Elizabeth del Nido Nothing to disclose

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact NeruoSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.